Personal profile
Research interests
Pharmaceutical Chemistry
Fingerprint
Dive into the research topics where Jeyaprakash R S is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Identification of thiazolidin-4-one scaffold-based molecules as PI3Kα inhibitors: Molecular docking, MM/GBSA, IFD, ADMET, water–map analysis, and MD simulations
Krishnan, K. P., Mangala Shenoy, K., Kini, S. G. & Jeyaprakash, R. S., 01-2026, In: Journal of Applied Pharmaceutical Science. 16, 1, p. 244-264 21 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Exploring target selectivity in designing and identifying PI3Kα inhibitors for triple negative breast cancer with fragment-based and bioisosteric replacement approach
Halder, D., Mukherjee, S. & Jeyaprakash, R. S., 12-2025, In: Scientific Reports. 15, 1, p. 1890 1 p., 1890.Research output: Contribution to journal › Article › peer-review
Open Access6 Link opens in a new tab Citations (Scopus) -
A Structure-Based Design Strategy with Pyrazole-Pyridine Derivatives Targeting TNFα as Anti-Inflammatory Agents: E-Pharmacophore, Dynamic Simulation, Synthesis and In Vitro Evaluation
Halder, D., Jeyaprakash, R. S. & Ghosh, B., 2024, (Accepted/In press) In: Chemistry and Biodiversity. 21, 9, e202400778.Research output: Contribution to journal › Article › peer-review
4 Link opens in a new tab Citations (Scopus) -
Computational-guided approach for identification of PI3K alpha inhibitor in the treatment of hepatocellular carcinoma by virtual screening and water map analysis
Das, S., Halder, D. & Jeyaprakash, R. S., 2023, (Accepted/In press) In: Journal of Biomolecular Structure and Dynamics.Research output: Contribution to journal › Article › peer-review
8 Link opens in a new tab Citations (Scopus) -
Identification of natural product as selective PI3Kα inhibitor against NSCLC: multi-ligand pharmacophore modeling, molecular docking, ADME, DFT, and MD simulations
Halder, D., Das, S. & Jeyaprakash, R. S., 2023, (Accepted/In press) In: Molecular Diversity. 28, 5, p. 2983-3010 28 p.Research output: Contribution to journal › Article › peer-review
15 Link opens in a new tab Citations (Scopus)